HCID 57455389, compound → HCID 69507057, compound
Reaction equation
[CH2:1]([C:4]1[N:5]([CH2:17][CH2:18][CH2:19][C:20]([O:22]CC)=O)[C:6]2[C:15]3[N:14]=[CH:13][CH:12]=[CH:11][C:10]=3[N:9]=[CH:8][C:7]=2[N:16]=1)[CH2:2][CH3:3].[CH2:25](C1N(CCCC(OCC)=O)C2C3N=CC=CC=3N=CC=2N=1)CCC>>[CH2:1]([C:4]1[N:5]([CH2:17][CH2:18][CH2:19][C:20](=[O:22])[CH3:25])[C:6]2[C:15]3[N:14]=[CH:13][CH:12]=[CH:11][C:10]=3[N:9]=[CH:8][C:7]=2[N:16]=1)[CH2:2][CH3:3]Participants
3
Procedure
A modified version of the general methods described in Parts D-G of Example 4 was sequentially followed with ethyl 4-(2-propyl-1H-imidazo[4,5-c][1,5]naphthyridin-1-yl)butyrate (6.0 g, 18.4 mmol) used in lieu of ethyl 4-(2-butyl-1H-imidazo[4,5-c][1,5]naphthyridin-1-yl)butyrate as the starting substrate. Isolation after the last step of the sequence afforded 6.06 g of crude 5-(2-propyl-1H-imidazo[4,5-c][1,5]naphthyridin-1-yl)pentan-2-one.
Sources & evidence
- ORD record
- ord-8fde47119c094c88aa0b8eda1dd8e427
- Source dataset
- uspto-grants-2014_07
- Patent number
- US08778963B2
Reaction notes
Loading…